Please assess the completion status of the following clinical trial:

Trial Title: Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Clinically diagnosed chronic allergic rhinitis or chronic sinusitis with no or a mild status of nasal polyp activity~* Disease lasting 12 weeks or longer~* Patients with moderate or severe symptoms (SNOT-22 score \>20)~* Male or female at least 18 years old~* Females in childbearing age are requested to make a pregnancy test and to confirm in writing to take contraceptive measures until Follow-up Visit (Day 49).~* Patient understands German~Exclusion Criteria:~* Severely purulent forms of sinusitis~* History of medication during the last four weeks~  * not allowed: antibiotics, systemic or topical steroids~ * allowed: nasal saline spray or irrigation, analgesics, decongestants, antihistamines~* Patient has a status of moderate or severe polyp activity in the nose~* Patient had sinus surgery in the past 6 months~* Patient needs O2 substitution~* Patient has cystic fibrosis~* Patient has primary ciliary dyskinesia~* Patient is demented or otherwise incapable of judgement

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Jantar-1 (JT-1), 7% (w/w) aqueous solution (Type: EXPERIMENTAL): Dosing regimen: ad libitum between at least 2 doses, in the morning and in the evening, and at most 10 doses per day. A dose corresponds to two strokes of 100ul each per nostril.

Based on this trial design, predict the completion outcome and termination type (if applicable).